All - d - Enantiomeric Peptide D3 Designed for Alzheimer's Disease Treatment Dynamically Interacts with Membrane-Bound Amyloid-beta Precursors.
Bocharov, E.V., Gremer, L., Urban, A.S., Okhrimenko, I.S., Volynsky, P.E., Nadezhdin, K.D., Bocharova, O.V., Kornilov, D.A., Zagryadskaya, Y.A., Kamynina, A.V., Kuzmichev, P.K., Kutzsche, J., Bolakhrif, N., Muller-Schiffmann, A., Dencher, N.A., Arseniev, A.S., Efremov, R.G., Gordeliy, V.I., Willbold, D.(2021) J Med Chem 64: 16464-16479
- PubMed: 34739758 
- DOI: 10.1021/acs.jmedchem.1c00632
- Primary Citation of Related Structures:  
7B3J, 7B3K - PubMed Abstract: 
Alzheimer's disease (AD) is a severe neurodegenerative pathology with no effective treatment known. Toxic amyloid-β peptide (Aβ) oligomers play a crucial role in AD pathogenesis. All - d - Enantiomeric peptide D3 and its derivatives were developed to disassemble and destroy cytotoxic Aβ aggregates ...